Analysis: Drug company and scientific partners at Oxford University have strongly pushed back against German press report
A row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned.
Continue reading…
Source: The Guardian